In a July 28 report appearing on bioRxiv, researchers in Japan have noted that the C.37 variant, dubbed Lambdais just as virulent as Delta and even more contagious.
The strain has been contained in 26 countries, including substantial outbreaks in Chile, Peru, Argentina and Ecuador.
“Notably, the vaccination rate in Chile is relatively high; the percentage of the people who received at least one dose of COVID-19 vaccine was [about] 60%,” the authors write.
“Nevertheless, a big COVID-19 surge has occurred in Chile in Spring 2021, suggesting that the Lambda variant is proficient in escaping from the antiviral immunity elicited by vaccination.”
The Lambda variant is thought to have emerged somewhere in South America between November and December 2020, and has since turned up in countries throughout Europe, North America and a few more isolated cases in Asia, according to GISAID data.
Note: Lambda variant is spreading throughout South America, meanwhile President Biden has left our southern border open…Lambda may be vaccine-resistant. Pay attention to where this is going.
“In addition to increasing viral infectivity, the Delta variant exhibits higher resistance to the vaccine-induced neutralization,” the authors said. “Similarly, here we showed that the Lambda variant equips not only increased infectivity but also resistance against antiviral immunity.”
Lambda has so far been labeled a “variant of interest” by the World Health Organization, compared to the Alpha, Beta, Gamma and Delta strains, which have all risen to “variant of concern,” or VOC, status.
The US Centers for Disease Control and Prevention has been quiet on the Lambda variant. Doctors are still urging folks to get vaccinated in order minimalize the effects if infection occurs.